These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2476907)

  • 1. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
    Odink J; Kärkelä J; Thissen JT; Marnela KM
    Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
    Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
    Kärkelä J; Scheinin M
    J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
    Degrell I; Nagy E
    Biol Psychiatry; 1990 May; 27(10):1179-82. PubMed ID: 1692743
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
    Beckmann H; Waldmeier P; Lauber J; Gattaz WF
    J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.
    Cooper SJ; Leahey W; Green DF; King DJ
    Br J Psychiatry; 1988 Jan; 152():59-63. PubMed ID: 2458796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M; Chang WH; Kirk KL; Linnoila M
    Anal Biochem; 1983 May; 131(1):246-53. PubMed ID: 6193730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
    Sedvall GC; Wode-Helgodt B
    Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.